ArticleJournal of experimental & clinical cancer research : CR2023

Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer.

Namhee Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.